Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy

Chao Gao, Wenzheng Zhang
doi: https://doi.org/10.1101/486027
Chao Gao
Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenzheng Zhang
Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

AQP5 has been shown to be upregulated in kidney biopsies from patients with diabetic nephropathy. Here we investigate whether urinary baseline AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy. Baseline urine samples (n=997) from patients with type 2 diabetes and nephropathy recruited in the Sun-MACRO randomized placebo controlled double blind clinical trial were used for AQP5 measurement, using human AQP5-specific enzyme linked immunosorbent kits. Pearson correlation and multiple linear regression between AQP5 with eGFR slope (calculated by ≥3 serum creatinine during followup) was performed, and association with fast renal function decline, defined as eGFR slope less than 3.0 mL/min/1.73m2/year, was determined by logistic regression. Followup eGFR data over 1.4 years from n=700 were available for analysis. AQP5 was undetectable in 138 patients. Tertiles of AQP5 were 0.4 [0 - 2.2], 7.3 [5.9 - 9.1], and 16.0 [13.0 - 21.6] (ng/mL), respectively (p<0.01). Patients in the highest tertile of AQP5 had significantly higher total cholesterol, lower baseline eGFR, and higher levels of albuminuria compared to the lowest tertile. AQP5 was inversely correlated with eGFR slope (Pearson r = -0.12, p<0.001), and independent of clinical risk factors age, sex, race, and baseline SBP, DBP, HbA1c, Tot. Cholesterol, eGFR, and UACR (β = -0.05, p<0.004). Furthermore, AQP5 was significantly associated with fast eGFR decline (OR = 1.03 (95%CI 1.003 - 1.06), p<0.03). Our data suggest that baseline AQP5 is independently associated with the progression of eGFR decline in patients with type 2 diabetes and nephropathy.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 04, 2018.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy
Chao Gao, Wenzheng Zhang
bioRxiv 486027; doi: https://doi.org/10.1101/486027
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy
Chao Gao, Wenzheng Zhang
bioRxiv 486027; doi: https://doi.org/10.1101/486027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Physiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (2633)
  • Biochemistry (5221)
  • Bioengineering (3643)
  • Bioinformatics (15709)
  • Biophysics (7213)
  • Cancer Biology (5592)
  • Cell Biology (8042)
  • Clinical Trials (138)
  • Developmental Biology (4732)
  • Ecology (7458)
  • Epidemiology (2059)
  • Evolutionary Biology (10518)
  • Genetics (7697)
  • Genomics (10081)
  • Immunology (5148)
  • Microbiology (13823)
  • Molecular Biology (5354)
  • Neuroscience (30576)
  • Paleontology (211)
  • Pathology (871)
  • Pharmacology and Toxicology (1519)
  • Physiology (2234)
  • Plant Biology (4983)
  • Scientific Communication and Education (1036)
  • Synthetic Biology (1379)
  • Systems Biology (4130)
  • Zoology (803)